Carolina Infusion & Compounding
Carolina Infusion & Compounding is a 503A compounding pharmacy based in Ridgeland, SC. A government record names semaglutide and tirzepatide at Carolina Infusion & Compounding; the newest is an FDA recall dated September 10, 2026. It fills prescriptions; it doesn’t write them, so you can’t get a GLP-1 from Carolina Infusion & Compounding without a prescription from a licensed clinician.1
How to get a GLP‑1 filled by Carolina Infusion & CompoundingChecked November 20, 2026 against FDA, CMS and state board records. Every fact links to its source.
Carolina Infusion & Compounding at a glance
How to get a GLP‑1 filled by Carolina Infusion & Compounding
To get a GLP‑1 from Carolina Infusion & Compounding, you first need a prescription: it fills prescriptions; it doesn’t write them or sell without one. An online program takes you through the steps: you fill in a health questionnaire, a licensed clinician reviews it, and if they prescribe, the program’s pharmacy ships the medication to you.
These are the three programs ranked highest on our score. Check that a program ships to your state before you sign up.
- 1Health questionnaire, online
- 2A licensed clinician decides
- 3The pharmacy ships to you
We may earn a commission when you sign up through some links. It never changes our order or scores. How we make money
Prefer your own clinician? You’re free to: ask them to send your prescription to Carolina Infusion & Compounding or another licensed pharmacy.
See every program we rankWhat ties Carolina Infusion & Compounding to GLP‑1s
- FDA recallSeptember 10, 2026 · semaglutideClass II recall D-0026-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.2
“SEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- FDA recallSeptember 10, 2026 · semaglutideClass II recall D-0019-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.3
“SEMAGLUTIDE/CYANOCOBALAMIN 3/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- FDA recallSeptember 10, 2026 · semaglutideClass II recall D-0018-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.4
“SEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- FDA recallSeptember 10, 2026 · tirzepatideClass II recall D-0027-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.5
“TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- FDA recallSeptember 10, 2026 · tirzepatideClass II recall D-0030-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.6
“TIRZEPATIDE/CYANOCOBALAMIN 85/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;”
- FDA recallSeptember 10, 2026 · tirzepatideClass II recall D-0028-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.7
“TIRZEPATIDE/CYANOCOBALAMIN 64/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- FDA recallSeptember 10, 2026 · tirzepatideClass II recall D-0029-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.8
“TIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- FDA recallSeptember 10, 2026 · tirzepatideClass II recall D-0017-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.9
“TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;”
- FDA inspection report (Form 483)August 18, 2026 · tirzepatideFDA Form 483 inspectional observations, Carolina Infusion, issued 2026-08-1810
“bulk stock solutions of drug products, such as tirzepatide, are stored in unclassified areas”
- FDA inspection report (Form 483)January 24, 2025 · semaglutideFDA Form 483 inspectional observations, Carolina Infusion, issued 2025-01-2411
“pre-filled syringes of Semaglutide/Cyanocobalamin 9/2 mg/mL injection”
- FDA recallAugust 26, 2022 · semaglutideClass II recall D-1521-2022: Lack of Assurance of Sterility12
“Semaglutide/Cyanocobalamin 24/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.”
- FDA recallAugust 26, 2022 · semaglutideClass II recall D-1519-2022: Lack of Assurance of Sterility13
“Semaglutide/Cyanocobalamin 5/2 MG/ML Injectable, 0.2 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.”
- FDA recallAugust 26, 2022 · semaglutideClass II recall D-1520-2022: Lack of Assurance of Sterility14
“Semaglutide/Cyanocobalamin 10/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.”
Carolina Infusion & Compounding’s FDA record
| Date | What the FDA did |
|---|---|
| August 18, 2026 | 483 Issued 08/18/202615 |
| January 24, 2025 | 483 Issued 01/24/202516 |
| May 22, 2023 | Warning Letter (05/22/2023)17 |
| August 12, 2022 | 483 Issued 08/12/202218 |
What a compounded GLP‑1 is, and what it isn’t
The bigger question with any compounded program is the drug itself. Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn’t review their safety, effectiveness or quality before they’re sold, and they are not the same as Wegovy or Zepbound. Formulas can differ from one pharmacy to the next, and some add ingredients such as vitamin B12.2324 Compounding pharmacies are licensed and inspected by state boards of pharmacy; outsourcing facilities (503B) also register with the FDA and are inspected by it. The FDA can issue warning letters when either breaks rules on safety or sterility.2219
Carolina Infusion & Compounding: questions
- 1.NPI Registry: CAROLINA INFUSION (NPI 1831461052)Centers for Medicare & Medicaid Servicesretrieved 2026-11-20↩
- 2.Class II recall D-0026-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.U.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-09-10↩“SEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- 3.Class II recall D-0019-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.U.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-09-10↩“SEMAGLUTIDE/CYANOCOBALAMIN 3/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- 4.Class II recall D-0018-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.U.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-09-10↩“SEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- 5.Class II recall D-0027-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.U.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-09-10↩“TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- 6.Class II recall D-0030-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.U.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-09-10↩“TIRZEPATIDE/CYANOCOBALAMIN 85/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;”
- 7.Class II recall D-0028-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.U.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-09-10↩“TIRZEPATIDE/CYANOCOBALAMIN 64/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- 8.Class II recall D-0029-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.U.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-09-10↩“TIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936”
- 9.Class II recall D-0017-2027: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.U.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-09-10↩“TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;”
- 10.FDA Form 483 inspectional observations, Carolina Infusion, issued 2026-08-18FDAretrieved 2026-08-18↩“bulk stock solutions of drug products, such as tirzepatide, are stored in unclassified areas”
- 11.FDA Form 483 inspectional observations, Carolina Infusion, issued 2025-01-24FDAretrieved 2025-01-24↩“pre-filled syringes of Semaglutide/Cyanocobalamin 9/2 mg/mL injection”
- 12.Class II recall D-1521-2022: Lack of Assurance of SterilityU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2022-08-26↩“Semaglutide/Cyanocobalamin 24/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.”
- 13.Class II recall D-1519-2022: Lack of Assurance of SterilityU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2022-08-26↩“Semaglutide/Cyanocobalamin 5/2 MG/ML Injectable, 0.2 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.”
- 14.Class II recall D-1520-2022: Lack of Assurance of SterilityU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2022-08-26↩“Semaglutide/Cyanocobalamin 10/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.”
- 15.FDA: 483 Issued 08/18/2026 (PDF - 2 MB)U.S. Food and Drug Administration↩
- 16.FDA: 483 Issued 01/24/2025 (PDF - 1 MB)U.S. Food and Drug Administration↩
- 17.FDA: Warning Letter (05/22/2023)U.S. Food and Drug Administration↩
- 18.FDA: 483 Issued 08/12/2022 (PDF - 918 KB)U.S. Food and Drug Administration↩
- 19.Compounding inspections, recalls, and other actionsU.S. Food and Drug Administrationretrieved 2026-11-20↩
- 20.South Carolina license lookupverify.llronline.com↩
- 21.Carolina Infusion & Compounding: where it shipscarolinainfusion.comretrieved 2026-11-20↩“We can also offer our services to the regions of South Carolina, Georgia, New York, and Illinois.”
- 22.Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration↩
- 23.
- 24.
A pharmacy’s record can change after the day we read it: check its license with its state board before you fill a prescription. An FDA document is an allegation or an observation the FDA has published, not a court finding. This page is educational and is not medical advice.